Ulcerative Colitis, Active Severe Completed Phase 1 Trials for Izencitinib (DB16660)

Also known as: Severe, active Ulcerative colitis

IndicationStatusPhase
DBCOND0059114 (Ulcerative Colitis, Active Severe)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)Treatment